Day One Biopharmaceuticals (DAWN) FY Conference Transcript

Day One Biopharmaceuticals (DAWN) FY Conference June 10, 2025 08:40 AM ET Speaker0 Good morning, everyone. Thanks so much for joining us. I'm Andrea Newkirk, one of the biotech analysts here at Goldman Sachs, and I'm really pleased to be joined by Jeremy Bender, COO and CFO of Dawn. Thank you guys both for joining us. Speaker1 Andrea, thanks for having us. It's great to be here. Speaker0 Great. Well, as we sit here today, Ogemda has been on the market now for over a year. What has been the biggest learnings ...